Abstract
Diabetic retinopathy shares some similarity with chronic inflammation and Müller cells dysfunction may play an important role in its initiation and progression since these cells are thought to be a major source of inflammatory factors. The goal of this study was to examine the effect of cytokines on human retinal Müller cells and to understand the underlying signal transduction pathways regulating interleukin-8 (IL-8) expression. In this study, human MIO-M1 cells were treated with interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), IL-8, vascular endothelial growth factor (VEGF), interferon-gamma (IFN-γ), glucose, or mannitol, followed by examination of their IL-8 protein and mRNA levels by Western blotting and PCR, respectively. After treatment with IL-1β, the levels of phosphorylated p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated protein kinases 1 and 2 (ERK1/2), c-Jun N-terminal kinase (JNK), Janus kinase 2 (JAK2), and signal transducer and activator of transcription 3 (STAT3) were measured. IL-8 was also measured by Western blotting and ELISA following Müller cell culture with IL-1β and specific inhibitors of the p38 MAPK, ERK1/2, JNK, or JAK2 pathways. The results showed that IL-1β was a potent inducer of IL-8 expression in MIO-M1 cells, although a relatively small increase was induced by TNF-α. IL-6, IL-8, VEGF, and IFN-γ did not modify IL-8 expression. Increase of IL-8 expression was accompanied by a significant increased phosphorylation of p38 MAPK, ERK, and JNK, but not of JAK2 and STAT3. Furthermore, inhibitors of p38 MAPK and MEK1/2, but not for JNK and JAK2, significantly inhibited IL-8 expression. In conclusion, IL-1β potently stimulates IL-8 expression in Müller cells mainly through the p38 MAPK and ERK1/2 pathways.
Similar content being viewed by others
REFERENCES
Schroder, S., W. Palinski, and G.W. Schmid-Schonbein. 1991. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. The American Journal of Pathology 139: 81–100.
Mackinnon, J.R., R.M. Knott, and J.V. Forrester. 2004. Altered L-selectin expression in lymphocytes and increased adhesion to endothelium in patients with diabetic retinopathy. British Journal of Ophthalmology 88: 1137–1141.
Yuuki, T., T. Kanda, Y. Kimura, N. Kotajima, J. Tamura, I. Kobayashi, and S. Kishi. 2001. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. Journal of Diabetic Complications 15: 257–259.
El-Asrar, A.M., M.I. Nawaz, D. Kangave, K. Geboes, M.S. Ola, S. Ahmad, and M. Al-Shabrawey. 2011. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Molecular Vision 17: 1829–1838.
Demircan, N., B.G. Safran, M. Soylu, A.A. Ozcan, and S. Sizmaz. 2006. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (London, England) 20: 1366–1369.
Scuderi, S., A.G. D'amico, A. Castorina, R. Imbesi, M.L. Carnazza, and V. D'agata. 2013. Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction. Peptides 39: 119–124.
Liu, Y., M. Biarnes Costa, and C. Gerhardinger. 2012. IL-1beta is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1beta autostimulation. PLoS One 7: e36949.
Agrawal, S.S., S. Naqvi, S.K. Gupta, and S. Srivastava. 2012. Prevention and management of diabetic retinopathy in STZ diabetic rats by Tinospora cordifolia and its molecular mechanisms. Food and Chemical Toxicology 50: 3126–3132.
Krady, J.K., A. Basu, C.M. Allen, Y. Xu, K.F. Lanoue, T.W. Gardner, and S.W. Levison. 2005. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54: 1559–1565.
Shen, X., B. Xie, Y. Cheng, Q. Jiao, and Y. Zhong. 2011. Effect of pigment epithelium derived factor on the expression of glutamine synthetase in early phase of experimental diabetic retinopathy. Ocular Immunology and Inflammation 19: 246–254.
Zhang, Y., G. Xu, Q. Ling, and C. Da. 2011. Expression of aquaporin 4 and Kir4.1 in diabetic rat retina: treatment with minocycline. Journal of International Medical Research 39: 464–479.
Gustavsson, C., C.D. Agardh, P. Hagert, and E. Agardh. 2008. Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion. Retina 28: 645–652.
El-Ghrably, I.A., H.S. Dua, G.M. Orr, D. Fischer, and P.J. Tighe. 2001. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. British Journal of Ophthalmology 85: 461–470.
Dong, N., B. Xu, B. Wang, and L. Chu. 2013. Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy. Molecular Vision 19: 1734–1746.
Suzuki, Y., M. Nakazawa, K. Suzuki, H. Yamazaki, and Y. Miyagawa. 2011. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Japanese Journal of Ophthalmology 55: 256–263.
Zhou, J., S. Wang, and X. Xia. 2012. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Current Eye Research 37: 416–420.
Johnsen-Soriano, S., M. Sancho-Tello, E. Arnal, A. Navea, E. Cervera, F. Bosch-Morell, M. Miranda, and F. Javier Romero. 2010. IL-2 and IFN-gamma in the retina of diabetic rats. Graefe's Archive for Clinical and Experimental Ophthalmology 248: 985–990.
Kawashima, M., J. Shoji, Y. Kamura, and Y. Sato. 2005. Role of chemokines in the vitreous of proliferative diabetic retinopathy. Nihon Ganka Gakkai Zasshi 109: 596–602.
Baggiolini, M., and I. Clark-Lewis. 1992. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Letters 307: 97–101.
Jorens, P.G., J.B. Richman-Eisenstat, B.P. Housset, P.D. Graf, I.F. Ueki, J. Olesch, and J.A. Nadel. 1992. Interleukin-8 induces neutrophil accumulation but not protease secretion in the canine trachea. American Journal of Physiology 263: L708–L713.
Srinivasan, S., M. Yeh, E.C. Danziger, M.E. Hatley, A.E. Riggan, N. Leitinger, J.A. Berliner, and C.C. Hedrick. 2003. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circulation Research 92: 371–377.
Gesser, B., M. Lund, N. Lohse, C. Vestergaad, K. Matsushima, S. Sindet-Pedersen, S.L. Jensen, K. Thestrup-Pedersen, and C.G. Larsen. 1996. IL-8 induces T cell chemotaxis, suppresses IL-4, and up-regulates IL-8 production by CD4+ T cells. Journal of Leukocyte Biology 59: 407–411.
Koch, A.E., P.J. Polverini, S.L. Kunkel, L.A. Harlow, L.A. Dipietro, V.M. Elner, S.G. Elner, and R.M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798–1801.
Koskela, U.E., S.M. Kuusisto, A.E. Nissinen, M.J. Savolainen, and M.J. Liinamaa. 2013. High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy. Ophthalmic Research 49: 108–114.
Arjamaa, O., M. Pollonen, K. Kinnunen, T. Ryhanen, and K. Kaarniranta. 2011. Increased IL-6 levels are not related to NF-kappaB or HIF-1alpha transcription factors activity in the vitreous of proliferative diabetic retinopathy. Journal of Diabetes and its Complications 25: 393–397.
Lange, C.A., P. Stavrakas, U.F. Luhmann, D.J. De Silva, R.R. Ali, Z.J. Gregor, and J.W. Bainbridge. 2011. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy. The American Journal of Pathology 152(406–412): e403.
Wakabayashi, Y., Y. Usui, Y. Okunuki, T. Kezuka, M. Takeuchi, T. Iwasaki, A. Ohno, and H. Goto. 2011. Increases of vitreous monocyte chemotactic protein 1 and interleukin 8 levels in patients with concurrent hypertension and diabetic retinopathy. Retina 31: 1951–1957.
Wakabayashi, Y., Y. Usui, Y. Okunuki, T. Kezuka, M. Takeuchi, H. Goto, and T. Iwasaki. 2010. Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy. Retina 30: 339–344.
Yoshimura, T., K.H. Sonoda, M. Sugahara, Y. Mochizuki, H. Enaida, Y. Oshima, A. Ueno, Y. Hata, H. Yoshida, and T. Ishibashi. 2009. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 4: e8158.
Murugeswari, P., D. Shukla, A. Rajendran, R. Kim, P. Namperumalsamy, and V. Muthukkaruppan. 2008. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales’ disease. Retina 28: 817–824.
Canataroglu, H., I. Varinli, A.A. Ozcan, A. Canataroglu, F. Doran, and S. Varinli. 2005. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Ocular Immunology and Inflammation 13: 375–381.
Hernandez, C., R.M. Segura, A. Fonollosa, E. Carrasco, G. Francisco, and R. Simo. 2005. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabetic Medicine 22: 719–722.
Cicik, E., H. Tekin, S. Akar, O.B. Ekmekci, O. Donma, L. Koldas, and S. Ozkan. 2003. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ophthalmic Research 35: 251–255.
Nicoletti, R., I. Venza, G. Ceci, M. Visalli, D. Teti, and A. Reibaldi. 2003. Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina. British Journal of Ophthalmology 87: 1038–1042.
Lee, W.J., M.H. Kang, M. Seong, and H.Y. Cho. 2012. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion. British Journal of Ophthalmology 96: 1426–1430.
Funk, M., G. Schmidinger, N. Maar, M. Bolz, T. Benesch, G.J. Zlabinger, and U.M. Schmidt-Erfurth. 2010. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 30: 1412–1419.
Jonas, J.B., R.A. Jonas, M. Neumaier, and P. Findeisen. 2012. Cytokine concentration in aqueous humor of eyes with diabetic macular edema. Retina 32: 2150–2157.
Lopez, P.F., H.E. Grossniklaus, H.M. Lambert, T.M. Aaberg, A. Capone Jr., P. Sternberg Jr., and N. L'hernault. 1991. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. The American Journal of Pathology 112: 647–656.
Roh, M.I., H.S. Kim, J.H. Song, J.B. Lim, H.J. Koh, and O.W. Kwon. 2009. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment. Retina 29: 523–529.
Ahmad, I., C.B. Del Debbio, A.V. Das, and S. Parameswaran. 2011. Muller glia: a promising target for therapeutic regeneration. Investigative Ophthalmology & Visual Science 52: 5758–5764.
Newman, E., and A. Reichenbach. 1996. The Muller cell: a functional element of the retina. Trends in Neurosciences 19: 307–312.
Zhong, Y., J. Li, Y. Chen, J.J. Wang, R. Ratan, and S.X. Zhang. 2012. Activation of endoplasmic reticulum stress by hyperglycemia is essential for Muller cell-derived inflammatory cytokine production in diabetes. Diabetes 61: 492–504.
Mizutani, M., C. Gerhardinger, and M. Lorenzi. 1998. Muller cell changes in human diabetic retinopathy. Diabetes 47: 445–449.
Takeda, M., A. Takamiya, A. Yoshida, and H. Kiyama. 2002. Extracellular signal-regulated kinase activation predominantly in Muller cells of retina with endotoxin-induced uveitis. Investigative Ophthalmology & Visual Science 43: 907–911.
Walker, R.J., and J.J. Steinle. 2007. Role of beta-adrenergic receptors in inflammatory marker expression in Muller cells. Investigative Ophthalmology & Visual Science 48: 5276–5281.
Goczalik, I., E. Ulbricht, M. Hollborn, M. Raap, S. Uhlmann, M. Weick, T. Pannicke, P. Wiedemann, A. Bringmann, A. Reichenbach, and M. Francke. 2008. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina. Investigative Ophthalmology & Visual Science 49: 4578–4589.
Limb, G.A., T.E. Salt, P.M. Munro, S.E. Moss, and P.T. Khaw. 2002. In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1). Investigative Ophthalmology & Visual Science 43: 864–869.
Lei, X., J. Zhang, J. Shen, L.M. Hu, Y. Wu, L. Mou, G. Xu, W. Li, and G.T. Xu. 2011. EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy. Frontiers in Bioscience (Elite edition) 3: 201–211.
Dinarello, C.A. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095–2147.
Rothwell, N.J., and G.N. Luheshi. 2000. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends in Neurosciences 23: 618–625.
Kowluru, R.A., and S. Odenbach. 2004. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. British Journal of Ophthalmology 88: 1343–1347.
Kumar, A., and N. Shamsuddin. 2012. Retinal Muller glia initiate innate response to infectious stimuli via toll-like receptor signaling. PLoS One 7: e29830.
Bian, Z.M., S.G. Elner, A. Yoshida, S.L. Kunkel, J. Su, and V.M. Elner. 2001. Activation of p38, ERK1/2 and NIK pathways is required for IL-1beta and TNF-alpha-induced chemokine expression in human retinal pigment epithelial cells. Experimental Eye Research 73: 111–121.
Shamsuddin, N., and A. Kumar. 2011. TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus. The Journal of Immunology 186: 7089–7097.
Vij, N., A. Sharma, M. Thakkar, S. Sinha, and R.R. Mohan. 2008. PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway. Molecular Vision 14: 1020–1027.
Cheranov, S.Y., D. Wang, V. Kundumani-Sridharan, M. Karpurapu, Q. Zhang, K.R. Chava, and G.N. Rao. 2009. The 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires Janus kinase 2-signal transducer and activator of transcription-5B-dependent expression of interleukin-8. Blood 113: 6023–6033.
ACKNOWLEDGMENTS
The author thanks Weihua Tong for reference input, and thanks Guodong Lian, Chang Shu, and Zhiqing Wang for technical support. No conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Liu, X., Ye, F., Xiong, H. et al. IL-1β Upregulates IL-8 Production in Human Müller Cells Through Activation of the p38 MAPK and ERK1/2 Signaling Pathways. Inflammation 37, 1486–1495 (2014). https://doi.org/10.1007/s10753-014-9874-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-014-9874-5